These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1147 related items for PubMed ID: 19699920
1. Survival of patients with true pathologic stage I non-small cell lung cancer. Cerfolio RJ, Bryant AS. Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920 [Abstract] [Full Text] [Related]
6. Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer. Cerfolio RJ, Bryant AS. Ann Thorac Surg; 2007 Jul; 84(1):182-8; discussion 189-90. PubMed ID: 17588408 [Abstract] [Full Text] [Related]
7. Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study. Cerfolio RJ, Bryant AS. J Thorac Cardiovasc Surg; 2008 Feb; 135(2):261-8. PubMed ID: 18242247 [Abstract] [Full Text] [Related]
8. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer. Meyers BF, Haddad F, Siegel BA, Zoole JB, Battafarano RJ, Veeramachaneni N, Cooper JD, Patterson GA. J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440 [Abstract] [Full Text] [Related]
9. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection]. Wei WD, Wen ZS, Su XD, Lin P, Rong TH, Chen LK. Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324 [Abstract] [Full Text] [Related]
10. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer. Cerfolio RJ, Bryant AS, Minnich DJ. Ann Thorac Surg; 2012 Sep; 94(3):902-6. PubMed ID: 22776083 [Abstract] [Full Text] [Related]
11. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer]. Ma K, Wang TY, He BL, Chang D, Gong M. Zhonghua Wai Ke Za Zhi; 2008 May 01; 46(9):670-3. PubMed ID: 18956719 [Abstract] [Full Text] [Related]
12. Accessing the aortopulmonary window (#5) and the paraaortic (#6) lymph nodes in patients with non-small cell lung cancer. Cerfolio RJ, Bryant AS, Eloubeidi MA. Ann Thorac Surg; 2007 Sep 01; 84(3):940-5. PubMed ID: 17720403 [Abstract] [Full Text] [Related]
17. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer. Kang CH, Ra YJ, Kim YT, Jheon SH, Sung SW, Kim JH. Ann Thorac Surg; 2008 Oct 01; 86(4):1092-7. PubMed ID: 18805138 [Abstract] [Full Text] [Related]
18. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease. Hsu CP, Hsia JY, Chang GC, Chuang CY, Shai SE, Yang SS, Lee MC, Kwan PC. J Thorac Cardiovasc Surg; 2009 Aug 01; 138(2):426-33. PubMed ID: 19619791 [Abstract] [Full Text] [Related]
19. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer]. Su XD, Wang X, Rong TH, Long H, Fu JH, Lin P, Zhang LJ, Wang SY, Wen ZS, Ma GW. Zhonghua Wai Ke Za Zhi; 2007 Nov 15; 45(22):1543-5. PubMed ID: 18282391 [Abstract] [Full Text] [Related]
20. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival. Hung JJ, Wang CY, Huang MH, Huang BS, Hsu WH, Wu YC. J Thorac Cardiovasc Surg; 2007 Sep 15; 134(3):638-43. PubMed ID: 17723811 [Abstract] [Full Text] [Related] Page: [Next] [New Search]